Literature DB >> 3703484

What is the most suitable grid for computer perimetry in glaucoma patients?

J Weber, K Dobek.   

Abstract

100 eyes with suspected or proven glaucoma were examined with the Humphrey Field Analyzer 620 with 30-1 and 30-2 threshold tests, complementary 6 degrees grids which combine to a 4.2 degrees grid. The two tests were compared with each other in the resulting 68 pathological fields. 29 of them showed obvious differences in detection of scotomas. In 11 fields, the differences were so great that isolated consideration would have led to an incorrect staging of the glaucoma. Therefore, at present both tests should be applied in glaucoma cases. The frequency of different scotoma detection per test location was more than 10 times higher in the center than in the periphery. It is suggested that a program is developed with a 3 degrees grid within 10 degrees eccentricity, a 4.2 degrees grid between 10 degrees and 20 degrees and a 6 degrees grid between 20 degrees and 30 degrees eccentricity.

Entities:  

Mesh:

Year:  1986        PMID: 3703484     DOI: 10.1159/000309619

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  4 in total

1.  High spatial resolution automated perimetry in glaucoma.

Authors:  M C Westcott; A I McNaught; D P Crabb; F W Fitzke; R A Hitchings
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

2.  [Practical aspects of glaucoma perimetry].

Authors:  J Weber
Journal:  Ophthalmologe       Date:  2013-11       Impact factor: 1.059

3.  Use of high spatial resolution perimetry to identify scotomata not apparent with conventional perimetry in the nasal field of glaucomatous subjects.

Authors:  M C Westcott; D F Garway-Heath; F W Fitzke; D Kamal; R A Hitchings
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

4.  Modeling the relative influence of fixation and sampling errors on retest variability in perimetry.

Authors:  T Maddess
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-30       Impact factor: 3.117

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.